Press release

Bureau Veritas Littleton Approved FDA ASCA Testing Laboratory

Apr. 8 2024

Bureau Veritas is pleased to announce the Littleton, Massachusetts laboratory has been accredited by the U.S. Food & Drug Administration (FDA) as an approved ASCA Testing Laboratory.

The FDA’s voluntary Accreditation Scheme for Conformity Assessment (ASCA) program is an accreditation scheme developed to streamline conformity assessment in device submissions, enhance the FDA’s confidence in test methods and results, and ultimately intended to help the FDA ensure patients have timely and continued access to safe, effective, and high-quality medical devices.

“In combination with our superior Medical Engineering team and our new FDA ASCA accreditation, our customers will have a path to streamline the FDA reviews and approval process and access the market at a faster rate,” noted Ozgur Ozturk, General Manager of BV Littleton Lab.

Please contact Bureau Veritas Littleton (info@us.bureuaveritas.com) for assistance with your Medical Device testing and certification needs or to schedule a time with one of our experts to discuss your upcoming projects.

Click to view Bureau Veritas’ ASCA accredited test scope: https://www.fda.gov/medical-devices/division-standards-and-conformity-assessment/asca-accredited-testing-laboratories